TIDMRGT 
 
1 February 2011 
 
                             ReGen Therapeutics Plc 
                           ("ReGen" or the "Company") 
 
                             Amendment to Timetable 
 
ReGen  announces an amendment to the timetable  included in the circular sent to 
shareholders  on 12 January 2011 and  repeated in the  Result of General Meeting 
announcement issued on 28 January 2011. 
 
The amendments are as follows: 
 
  * The  original "Last day of dealings" line  has been reworded to clarify that 
    this  date refers exclusively to the last  day of dealings in ReGen Ordinary 
    Shares on AIM to allow entry on the Shareholder register prior to the Record 
    Time. This date has been amended from 10 February 2011 to 9 February 2011 to 
    allow for a T+3 settlement period. 
 
 
  * An  additional line has been included below  to clarify that the last day of 
    dealings  in ReGen  Ordinary Shares  cum entitlement  to participate  in the 
    Demerger is 17 February 2011; and 
 
 
  * A  further  additional  line  has  been  included  below to clarify that 18 
    February  2011 will be  the first  day on  which ReGen  Ordinary Shares will 
    begin  trading ex entitlement to participate  in the Demerger (under the new 
    name of Alexander David Investments PLC). 
 
 
 
The full revised timetable of future significant events relating to the Demerger 
is therefore as follows: 
 
 
Last  day of  dealings (with  a T+3 settlement) in               9 February 2011 
ReGen Ordinary Shares on AIM to allow entry on the 
Shareholder register prior to the Record Time 
 
 
Record  Time for  the purposes  of determining the 6.00 p.m. on 14 February 2011 
Shareholders   entitled   to  participate  in  the 
Demerger and the grant of New Warrants 
 
 
Bonus Issue                                                     15 February 2011 
 
 
Court Hearing to confirm Reduction of Capital                   16 February 2011 
 
 
Reduction of Capital becomes effective                          17 February 2011 
 
 
Last  day of dealings in  ReGen Ordinary Shares on              17 February 2011 
AIM cum entitlement to participate in Demerger 
 
 
Expected date of the Demerger                                   18 February 2011 
 
 
Change  of  name  of  ReGen  Therapeutics  Plc  to              18 February 2011 
Alexander David Investments PLC 
 
 
ReGen  Ordinary Shares begin trading under the new              18 February 2011 
name of Alexander David Investments PLC (AIM: ADI) 
ex entitlement to participate in the Demerger 
 
 
CREST accounts credited with NewCo Shares                       18 February 2011 
 
 
Posting of share certificates for the NewCo Shares               By 8 March 2011 
to certificated Shareholders 
 
 
Posting   of  warrant  certificates  for  the  New               By 8 March 2011 
Warrants to Shareholders 
 
 
Definitions of all defined terms referred to above are available in the circular 
sent  to shareholders  on 12 January  2011, which is  available at the Company's 
website at www.regentherapeutics.com. 
 
 
 
 
Enquiries: 
 
 ReGen Therapeutics Plc               +44 20 7153 4920 
 Percy Lomax 
 
 
 Cairn Financial Advisers LLP         +44 20 7148 7900 
 Nominated Adviser 
 Liam Murray / Avi Robinson 
 
 
 Alexander David Securities Limited   +44 20 7448 9820 
 Broker 
 David Scott / Nick Bealer 
 
 
 
 
 
 
 
 
 
This announcement is distributed by Thomson Reuters on behalf of 
Thomson Reuters clients. The owner of this announcement warrants that: 
(i) the releases contained herein are protected by copyright and 
    other applicable laws; and 
(ii) they are solely responsible for the content, accuracy and 
     originality of the information contained therein. 
 
Source: ReGen Therapeutics Plc via Thomson Reuters ONE 
 
[HUG#1484403]
Argent Biopharma (LSE:RGT)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025 Click aqui para mais gráficos Argent Biopharma.
Argent Biopharma (LSE:RGT)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025 Click aqui para mais gráficos Argent Biopharma.